These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 9539744

  • 1. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.
    Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S.
    Proc Natl Acad Sci U S A; 1998 Apr 14; 95(8):4374-9. PubMed ID: 9539744
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S.
    Oncogene; 2001 Jan 04; 20(1):133-40. PubMed ID: 11244511
    [Abstract] [Full Text] [Related]

  • 3. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
    Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP.
    Cancer Res; 2004 Mar 15; 64(6):1987-96. PubMed ID: 15026334
    [Abstract] [Full Text] [Related]

  • 4. Signaling through beta-catenin and Lef/Tcf.
    Novak A, Dedhar S.
    Cell Mol Life Sci; 1999 Oct 30; 56(5-6):523-37. PubMed ID: 11212302
    [Abstract] [Full Text] [Related]

  • 5. Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase.
    Oloumi A, McPhee T, Dedhar S.
    Biochim Biophys Acta; 2004 Apr 01; 1691(1):1-15. PubMed ID: 15053919
    [Abstract] [Full Text] [Related]

  • 6. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
    D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG.
    J Biol Chem; 2000 Oct 20; 275(42):32649-57. PubMed ID: 10915780
    [Abstract] [Full Text] [Related]

  • 7. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
    Porfiri E, Rubinfeld B, Albert I, Hovanes K, Waterman M, Polakis P.
    Oncogene; 1997 Dec 04; 15(23):2833-9. PubMed ID: 9419974
    [Abstract] [Full Text] [Related]

  • 8. Functional consequences of integrin-linked kinase activation in podocyte damage.
    Teixeira Vde P, Blattner SM, Li M, Anders HJ, Cohen CD, Edenhofer I, Calvaresi N, Merkle M, Rastaldi MP, Kretzler M.
    Kidney Int; 2005 Feb 04; 67(2):514-23. PubMed ID: 15673299
    [Abstract] [Full Text] [Related]

  • 9. Integrin-linked kinase (ILK): a "hot" therapeutic target.
    Yoganathan TN, Costello P, Chen X, Jabali M, Yan J, Leung D, Zhang Z, Yee A, Dedhar S, Sanghera J.
    Biochem Pharmacol; 2000 Oct 15; 60(8):1115-9. PubMed ID: 11007949
    [Abstract] [Full Text] [Related]

  • 10. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
    Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A.
    Genes Dev; 2002 Aug 15; 16(16):2058-72. PubMed ID: 12183361
    [Abstract] [Full Text] [Related]

  • 11. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F, Robinet C, Augé N, Thiers JC, Garcia V, Cambus JP, Salvayre R, Nègre-Salvayre A.
    Cancer Res; 2005 Jan 15; 65(2):526-32. PubMed ID: 15695395
    [Abstract] [Full Text] [Related]

  • 12. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
    Naishiro Y, Yamada T, Idogawa M, Honda K, Takada M, Kondo T, Imai K, Hirohashi S.
    Oncogene; 2005 Apr 28; 24(19):3141-53. PubMed ID: 15735679
    [Abstract] [Full Text] [Related]

  • 13. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
    Oloumi A, Syam S, Dedhar S.
    Oncogene; 2006 Dec 14; 25(59):7747-57. PubMed ID: 16799642
    [Abstract] [Full Text] [Related]

  • 14. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S, Casanova I, Farré L, Mazo A, Capellà G, Mangues R.
    Cancer Res; 2000 Dec 01; 60(23):6750-6. PubMed ID: 11118062
    [Abstract] [Full Text] [Related]

  • 15. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
    Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, Geiger B, Ben-Ze'ev A.
    J Cell Biol; 1998 Jun 15; 141(6):1433-48. PubMed ID: 9628899
    [Abstract] [Full Text] [Related]

  • 16. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.
    Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S.
    Proc Natl Acad Sci U S A; 1998 Sep 15; 95(19):11211-6. PubMed ID: 9736715
    [Abstract] [Full Text] [Related]

  • 17. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
    Easwaran V, Song V, Polakis P, Byers S.
    J Biol Chem; 1999 Jun 04; 274(23):16641-5. PubMed ID: 10347231
    [Abstract] [Full Text] [Related]

  • 18. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling.
    Wong MH, Huelsken J, Birchmeier W, Gordon JI.
    J Biol Chem; 2002 May 03; 277(18):15843-50. PubMed ID: 11854293
    [Abstract] [Full Text] [Related]

  • 19. Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.
    Naves MA, Requião-Moura LR, Soares MF, Silva-Júnior JA, Mastroianni-Kirsztajn G, Teixeira VP.
    J Nephrol; 2012 May 03; 25(3):401-9. PubMed ID: 21928230
    [Abstract] [Full Text] [Related]

  • 20. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
    Filali M, Cheng N, Abbott D, Leontiev V, Engelhardt JF.
    J Biol Chem; 2002 Sep 06; 277(36):33398-410. PubMed ID: 12052822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.